Patents-Review.com
ClassID:

21115 ⎘

A61K39/15 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Viral antigens Reoviridae, e.g. calf diarrhea virus

Recent Application in this class:
#1
20260077037
2026-03-19

CATIONIC LIPID BASED COMPOSITION, FORMULATION AND USE FOR NUCLEIC ACID VACCINE DELIVERY AND PREPARATION THEREOF

 #2
20260000749
2026-01-01

ROTAVIRUS VACCINES

 #3
20250295752
2025-09-25

VACCINE AGAINST INFECTIOUS BRONCHITIS

 #4
20250171502
2025-05-29

RECOMBINANT ROTA VIRUS EXPRESSION SYSTEM AND RECOMBINANT ROTA VIRUSES

 #5
20250057937
2025-02-20

COMPOSITIONS AND METHODS FOR EXPRESSING ANTIGENS ON CELL MEMBRANE

 #6
20240358825
2024-10-31

Novel Adjuvant Compositions

 #7
20240325596
2024-10-03

MINERAL-COATED SUBSTRATES FOR STABILIZATION OF RNA-BASED THERAPEUTIC COMPOSITIONS

 #8
20240156944
2024-05-16

ATTENUATED REOVIRUS-BASED VACCINE COMPOSITION AND USE THEREOF

 #9
20240050556
2024-02-15

OPTIMIZED POLYPEPTIDE FOR A SUBUNIT VACCINE AGAINST AVIAN REOVIRUS

 #10
20240050555
2024-02-15

IMMUNOGENIC COMPOSITION USEFUL FOR VACCINATION AGAINST ROTAVIRUS

 #11
20240043509
2024-02-08

Biological Therapeutics for Infection-Relating Disorders or Conditions

 #12
20240041760
2024-02-08

VACCINATION FOR PROTECTING POULTRY AGAINST A POULTRY PATHOGEN

 #13
20240000918
2024-01-04

Rotavirus vaccines

 #14
20240000813
2024-01-04

ADJUVANT CONTAINING ZINC ALUMINUM RISEDRONATE, AND APPLICATION THEREOF

 #15
20230348569
2023-11-02

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

 #16
20230190911
2023-06-22

VACCINE FORMULATIONS WITH INCREASED STABILITY

 #17
20230128782
2023-04-27

Rotavirus vaccines

 #18
20230105140
2023-04-06

INACTIVATED PISCINE ORTHOREOVIRUS VACCINE

 #19
20230000972
2023-01-05

ATTENUATED AVIAN REOVIRUS STRAINS 94826 C140 AND 97139 C140

 #20
20220370595
2022-11-24

Buffer Free, Acid Stable Low Dose Volume Rotavirus Vaccine

 #21
20220356230
2022-11-10

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

 #22
20220347295
2022-11-03

Vaccine delivery method

 #23
20220347288
2022-11-03

Method for producing artificial recombinant rotavirus

 #24
20220313813
2022-10-06

ROTAVIRUS MRNA VACCINE

 #25
20220175911
2022-06-09

Vaccine against infectious bronchitis

 #26
20220160866
2022-05-26

FUSION PROTEIN USEFUL FOR VACCINATION AGAINST ROTAVIRUS

 #27
20220111034
2022-04-14

VIRUS COMPOSITIONS

 #28
20220088186
2022-03-24

SAMRNA VACCINE AND PREPARATION METHOD THEREFOR

 #29
20220040288
2022-02-10

Human rotavirus G9P[6] strain and use as a vaccine

 #30
20220002350
2022-01-06

Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine

 #31
20210353739
2021-11-18

THERMAL INACTIVATION OF ROTAVIRUS

 #32
20210338810
2021-11-04

Adjuvant compositions

 #33
20210322537
2021-10-21

Method For Preparation of Quick Dissolving Thin Films Containing Bioactive Material With Enhanced Thermal Stability

 #34
20210308254
2021-10-07

Human rotavirus strains and vaccines

 #35
20210308253
2021-10-07

Vaccines against avian reoviruses

 #36
20210269488
2021-09-02

Recombinant rotavirus expression system and recombinant rotaviruses

 #37
20210205439
2021-07-08

Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine

 #38
20210145751
2021-05-20

Method for preserving biopharmaceuticals

 #39
20210048247
2021-02-18

METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

 #40
20210015916
2021-01-21

Vaccine delivery method

 #41
20200376112
2020-12-03

NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications

 #42
20200331949
2020-10-22

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

 #43
20200308258
2020-10-01

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

 #44
20200308233
2020-10-01

Truncated rotavirus VP4 protein and application thereof

 #45
20200121782
2020-04-23

Thermal inactivation of rotavirus

 #46
20200121781
2020-04-23

Human rotavirus G9P[6] strain and use as a vaccine

 #47
20200069788
2020-03-05

Avian reovirus vaccines

 #48
20200054735
2020-02-20

Human rotavirus strains and vaccines

 #49
20200009242
2020-01-09

Heat stable vaccines

 #50
20190383556
2019-12-19

METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

 #51
20190381165
2019-12-19

Vaccines and Diagnostics for Novel Porcine Orthoreoviruses

 #52
20190345232
2019-11-14

Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

 #53
20190343938
2019-11-14

Mammary tumor virus vaccine

 #54
20190290752
2019-09-26

Optimized polypeptide for a subunit vaccine against avian reovirus

 #55
20190282689
2019-09-19

Method for producing artificial recombinant rotavirus

 #56
20190275136
2019-09-12

VACCINE FORMULATIONS WITH INCREASED STABILITY

 #57
20190270792
2019-09-05

Biological therapeutics for infection-relating disorders or conditions

 #58
20190240315
2019-08-08

Vaccine against infectious bronchitis

 #59
20190192592
2019-06-27

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

 #60
20190175729
2019-06-13

Compositions

 #61
20190175722
2019-06-13

Multivalent vaccine composition

 #62
20190160164
2019-05-30

Rotavirus vaccines

 #63
20190142932
2019-05-16

Buffer free, acid stable low dose volume rotavirus vaccine

 #64
20190091325
2019-03-28

Human rotavirus G9P[6] strain and use as a vaccine

 #65
20190060442
2019-02-28

Reoviridae vaccine

 #66
20190038739
2019-02-07

Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine

 #67
20190008953
2019-01-10

Adjuvant compositions

 #68
20180346884
2018-12-06

MODIFIED HUMAN ROTAVIRUSES AND USES THEREFOR

 #69
20180333499
2018-11-22

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

 #70
20180326044
2018-11-15

NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications

 #71
20180326043
2018-11-15

Broad-spectrum vaccine against avian reovirus

 #72
20180243408
2018-08-30

TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED ALLERGY

 #73
20180236061
2018-08-23

Avian reovirus vaccines

 #74
20180236060
2018-08-23

Human rotavirus vaccine strains and diagnostics

 #75
20180228889
2018-08-16

Heat stable liquid rotavirus vaccine

 #76
20180141978
2018-05-24

Truncated rotavirus VP4 protein and application thereof

 #77
20180028644
2018-02-01

Thermal inactivation of rotavirus

 #78
20170304434
2017-10-26

Adjuvant compositions

 #79
20170258899
2017-09-14

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

 #80
20170247665
2017-08-31

A BLUETONGUE VACCINE AND METHODS OF MANUFACTURE THEREOF

 #81
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #82
20170196970
2017-07-13

Adjuvant for mucosal vaccine

 #83
20170173145
2017-06-22

Thermostable spray dried rotavirus vaccine formulation and process thereof

 #84
20170173144
2017-06-22

Human rotavirus vaccine strains and diagnostics

 #85
20170165354
2017-06-15

Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

 #86
20170095563
2017-04-06

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

 #87
20170028055
2017-02-02

Avian reovirus vaccines

 #88
20170007695
2017-01-12

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

 #89
20170000878
2017-01-05

Constrained immunogenic compositions and uses therefor

 #90
20160287694
2016-10-06

PISCINE REOVIRUS IMMUNOGENIC COMPOSITIONS

 #91
20160252300
2016-09-01

Method of microwave vacuum drying spherical-shaped pellets of biological materials

 #92
20160228540
2016-08-11

Nasal mucosal vaccine composition

 #93
20160213773
2016-07-28

Mucosal vaccine composition

 #94
20160193327
2016-07-07

Mucosal vaccine composition

 #95
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #96
20160158342
2016-06-09

Vaccines for diseases caused by viruses of the family of reoviridae

 #97
20160145583
2016-05-26

Methods for preparing inactivated rotavirus

 #98
20160058858
2016-03-03

Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same

 #99
20160024186
2016-01-28

Biological therapeutics for infection-relating disorders or conditions

 #100
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #101
20150337268
2015-11-26

Modified human rotaviruses and uses therefor

 #102
20150224155
2015-08-13

Liquid viral formulations

 #103
20150216961
2015-08-06

ROTAVIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

 #104
20150098967
2015-04-09

Rotavirus vaccine compositions and process for preparing the same

 #105
20150079122
2015-03-19

Human rotavirus vaccine strains and diagnostics

 #106
20140370054
2014-12-18

METHODS FOR INHIBITION OF TYPE 1 DIABETES

 #107
20140356396
2014-12-04

ROTAVIRUS PREPARATIONS WITH EXCESS CALCIUM IONS AND HIGH VISCOSITIES THAT ENSURE VIABILITY AT ELEVATED TEMPERATURES

 #108
20140302089
2014-10-09

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

 #109
20140255447
2014-09-11

PRODUCTION OF AVIAN EMBRYO CELLS

 #110
20140242113
2014-08-28

LIQUID VACCINE PREPARATIONS

 #111
20140178969
2014-06-26

Viral purification methods

 #112
20140134209
2014-05-15

Method for producing vaccinal viral strain of a virus of the family

 #113
20140120133
2014-05-01

Vaccine Against African Horse Sickness Virus

 #114
20140056940
2014-02-27

Adjuvant compositions

 #115
20130216567
2013-08-22

Avian group D rotavirus

 #116
20130209507
2013-08-15

Rotavirus subunit vaccines and methods of making and use thereof

 #117
20130164329
2013-06-27

CELL-BASED METHODS AND REAGENTS

 #118
20130149384
2013-06-13

THERMAL INACTIVATION OF ROTAVIRUS

 #119
20130072542
2013-03-21

Piscine reovirus diagnostic compositions

 #120
20130058969
2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

 #121
20130058968
2013-03-07

Piscine reovirus immunogenic compositions

 #122
20120252727
2012-10-04

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

 #123
20120237547
2012-09-20

Live attenuated rotavirus vaccine for oral administration

 #124
20120148570
2012-06-14

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS

 #125
20120141421
2012-06-07

Liquid viral formulations

 #126
20120121629
2012-05-17

Human rotavirus vaccine strains and diagnostics

 #127
20120114691
2012-05-10

VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS

 #128
20120107356
2012-05-03

Composition useful as rotavirus vaccine and a method therefor

 #129
20120093884
2012-04-19

Norovirus capsid and rotavirus VP6 protein for use as combined vaccine

 #130
20110311573
2011-12-22

Method for preparing recombinant antigen complex using rotavirus nanoparticle

 #131
20110305768
2011-12-15

QUICK-DISSOLVING ORAL THIN FILM FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

 #132
20110236420
2011-09-29

Bluetongue virus recombinant vaccines and uses thereof

 #133
20110236416
2011-09-29

FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF

 #134
20110177119
2011-07-21

Stable, dried rotavirus vaccine, compositions and process for preparation thereof

 #135
20110177116
2011-07-21

Methods of immunizing pregnant heifers at three months of gestation

 #136
20110150928
2011-06-23

Avian reoviridae and vaccines thereof

 #137
20110123560
2011-05-26

Infectious bursal disease virus antigenic isolates and vaccines

 #138
20110110980
2011-05-12

HETERLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN

 #139
20110104200
2011-05-05

Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines

 #140
20110091500
2011-04-21

Inactivated Live-Attenuated Bluetongue Virus Vaccine

 #141
20110033493
2011-02-10

VACCINE

 #142
20110027316
2011-02-03

Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same

 #143
20100322971
2010-12-23

Method for producing vaccinal viral strain of a virus of the reoviridae family

 #144
20100266628
2010-10-21

Macrocyclic lactone combination compositions, vaccines and methods for producing same

 #145
20100247622
2010-09-30

TREATMENT REGIME FOR PROLIFERATIVE DISORDERS

 #146
20100233208
2010-09-16

Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics

 #147
20100226939
2010-09-09

Formulations for preservation of rotavirus

 #148
20100215667
2010-08-26

METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS

 #149
20100209455
2010-08-19

Thermal inactivation of rotavirus

 #150
20100196919
2010-08-05

PEPTIDES, ANTIBODIES AND FRAGMENTS THEREOF FOR THE TREATMENT AND DIAGNOSTIC OF CELIAC DISEASE

 #151
20100119546
2010-05-13

Vaccine against african horse sickness virus

 #152
20100068227
2010-03-18

Stabilized liquid rotavirus vaccine composition

 #153
20100028371
2010-02-04

Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals

 #154
20100008951
2010-01-14

Flu vaccine admixture of mannan and flu antigen

 #155
20090324641
2009-12-31

Adjuvant compositions

 #156
20090136545
2009-05-28

PORCINE ROTAVIRUS REASSORTANT COMPOSITIONS

 #157
20090130145
2009-05-21

Homogeneous attenuated human rotavirus population

 #158
20090028828
2009-01-29

Rotavirus Vaccine Inducing Heterotypic Cross Protection

 #159
20080317776
2008-12-25

Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor

 #160
20080292660
2008-11-27

Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

 #161
20080274143
2008-11-06

Chloroplasts Engineering to Express Pharmaceutical Proteins

 #162
20080213304
2008-09-04

Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics

 #163
20080213263
2008-09-04

METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE DYSFUNCTION DISORDERS

 #164
20080193480
2008-08-14

Infectious Bursal Disease Virus antigenic isolates and vaccines

 #165
20080187553
2008-08-07

Immunstimulating lipid formulation

 #166
20080166372
2008-07-10

Live attenuated rotavirus vaccine for oral administration

 #167
20080138340
2008-06-12

METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS

 #168
20080063662
2008-03-13

VACCINE

 #169
20080057082
2008-03-06

Immunogenic composition of a homogeneous live attenuated human rotavirus population

 #170
20070275873
2007-11-29

Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting

 #171
20070269856
2007-11-22

Viral purification methods

 #172
20070031450
2007-02-08

Stabilizers for veterinary vaccines

 #173
20070020282
2007-01-25

Immunstimulating lipid formulation

 #174
20060140976
2006-06-29

Trivalent vaccine with maternal anitbody transfer via the milk

 #175
20050281842
2005-12-22

Inactivated bovine scours vaccines, process and method of preventing bovine scours

 #176
20050271674
2005-12-08

Methods and compositions for modulating the immune system of animals

 #177
20050266019
2005-12-01

Infectious bursal disease virus antigenic isolates and vaccines

 #178
20050075298
2005-04-07

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

 #179
20050048083
2005-03-03

Immunization with an attenuated human rotavirus

 #180
20050037085
2005-02-17

Microencapsulated DNA for vaccination and gene therapy

 #181
16912678
2020-09-29

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

 #182
15931939
2020-11-03

Molecules that bind to SARS-CoV-2